Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- (-) Legislation (15)
- Vaping hub (19)
- Compliance and enforcement (18)
- Advertising (16)
- Safety monitoring and information (12)
- Manufacturing (11)
- COVID-19 (8)
- Import and export (8)
- Labelling and packaging (8)
- Medicinal cannabis hub (6)
- Scheduling (national classification system) (5)
- Weight loss products (3)
- Clinical trials (2)
- Committees and advisory bodies (1)
- Fees and payments (1)
- Shortages and supply disruptions (1)
- Sunscreens (1)
Type of content
Search
15 result(s) found, displaying 1 to 15
-
News articlesFind out about new requirements for labels of injectable electrolyte medicines and updates to guidance for medicine sponsors.
-
News articlesFollowing our Essential Principles presentations on 11-12 September 2024, we have collated questions asked into themes to simplify finding information of relevance to you.
-
Regulatory decision noticesFind out how listed medicine ingredients and requirements for their use have been updated in the Therapeutic Goods (Permissible Ingredients) Determination (No. 3) which commenced on 27 September 2024.
-
Regulatory decision noticesThis instrument is made under the Therapeutic Goods Regulations 1990 and the Therapeutic Goods (Medical Devices) Regulations 2002.
-
News articlesTwo new quality standards, one for MDMA and another for psilocybine, have been published.
-
Regulatory decision noticesThis instrument is made under regulations 10AC, 10FA and 10HA of the Therapeutic Goods Regulations 1990.
-
Regulatory decision noticesThis instrument is made under regulations 10AB, 10F and 10H of the Therapeutic Goods Regulations 1990.
-
News articlesSome changes are rolling out soon to improve your experience using guidance on our website. We’re aiming to make our content clearer, more accessible and easier to navigate.
-
Regulatory decision noticesFind out how listed medicine ingredients and requirements for their use have been updated in the Therapeutic Goods (Permissible Ingredients) Determination (No. 2) 2024, which commenced on 14 June 2024.
-
Media releasesThe Minister for Health and Aged Care, the Hon Mark Butler MP, introduced a bill that aims to reduce the widespread availability of vapes by controlling all levels of the supply chain.
-
Regulatory decision noticesFind out how listed medicine ingredients, and requirements for their use, have been updated in the Therapeutic Goods (Permissible Ingredients) Determination (No. 1) 2024.
-
Media releasesThe TGA has issued 2 infringement notices totalling $37,560 to Queensland-based company Akula Foods Pty Ltd for the alleged unlawful import of unregistered complementary medicines
-
Media releasesThe Australian Border Force (ABF) and partners have seized more than five and a half million cigarette sticks and prevented hundreds of thousands of prohibited vapes and drug items from reaching the streets of Sydney.
-
Regulatory decision noticesThis instrument is made under regulation 97 of the Therapeutic Goods Regulations 1990.
-
Regulatory decision noticesThis instrument is made under Schedule 5A to the Therapeutic Goods Regulations 1990 and Schedule 4 to the Therapeutic Goods (Medical Devices) Regulations 2002.